✦ LIBER ✦

Botulinum Toxin Type B clinical safety in cervical dystonia following up to 4 years of treatment

✍ Scribed by Birmingham William; Pappert Eric; Salazar-Grueso Edgar

Book ID: 116922090
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 40 KB
Volume: 51
Category: Article
ISSN: 0041-0101
DOI: 10.1016/j.toxicon.2008.04.072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BotB (botulinum Toxin type B): Evaluatio

BotB (botulinum Toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-Resistant cervical dystonia patients (preliminary study)

✍ Dr. Daniel D. Truong; Paul A. Cullis; Christopher F. O'Brien; Martin Koller; Tim 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

## Abstract Botulinum toxin (BTX) injection is considered the treatment of choice for patients with cervical dystonia (torticollis). We conducted a pilot, open‐label, dose‐escalation study with BTX type B in 12 patients who no longer responded clinically to injections with BTX type A. At the doses

Long-term safety, efficacy, dosing, and

Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia

✍ Brian Berman; Lauren Seeberger; Rajeev Kumar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

## Abstract Short‐term studies of cervical dystonia (CD) have demonstrated botulinum toxin type B (Bot B) to be safe and efficacious at doses of 5,000 to 10,000 units, but few long‐term studies have been published and the safety and efficacy of higher doses has not been established. Additionally, t

Efficacy and safety of repeated doses of

Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia

✍ Stewart A. Factor; Eric S. Molho; Sharon Evans; Paul J. Feustel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Efficacy of botulinum toxin type B (BoNT B) for the treatment of type A‐resistant (AR) and non‐A‐resistant (NAR) cervical dystonia (CD) has been demonstrated in several single injection studies. There is little data available on long‐term therapy with repeated injection sessions and it

PND28 IMPROVEMENTS IN QUALITY OF LIFE FO

PND28 IMPROVEMENTS IN QUALITY OF LIFE FOLLOWING TREATMENT WITH BOTULINUM TOXIN TYPE A FOR CERVICAL DYSTONIA

✍ R Carlton; T Bramley; MV Shah; JE Hansen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

A 2-year open-label study of botulinum t

A 2-year open-label study of botulinum toxin type B in botulinum toxin type A resistant/responsive cervical dystonia patients (AN072-401 EU/CD)

✍ Moore Peter; Ferreira Joaquim; Pappert Eric 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB

0891 Comparison of the safety and effica

0891 Comparison of the safety and efficacy of botulinum toxin type-A and tizanidine in the treatment of cervical dystonia

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB